| 1 |
Ahmed A, Köhler S, Klotz R, Giese N, Hackert T, Springfeld C, Jäger D, Halama N. Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Cancers 2023;15:1815. [DOI: 10.3390/cancers15061815] [Reference Citation Analysis]
|
| 2 |
Roth L, Michl P, Rosendahl J. [Sex-specific differences in gastroenterological diseases]. Inn Med (Heidelb) 2023. [PMID: 36884055 DOI: 10.1007/s00108-023-01491-4] [Reference Citation Analysis]
|
| 3 |
GenoMed4All consortium. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. Lancet Haematol 2023;10:e117-28. [PMID: 36436542 DOI: 10.1016/S2352-3026(22)00323-4] [Reference Citation Analysis]
|
| 4 |
Stabellini N, Tomlinson B, Cullen J, Shanahan J, Waite K, Montero AJ, Barnholtz-Sloan JS, Hamerschlak N. Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival. Cancer Med 2022. [PMID: 36419242 DOI: 10.1002/cam4.5461] [Reference Citation Analysis]
|
| 5 |
Tagliabue M, D’ecclesiis O, De Berardinis R, Gaeta A, Martinoli C, Piana AF, Maffini F, Gandini S, Ansarin M, Chiocca S. The prognostic role of sex and hemoglobin levels in patients with oral tongue squamous cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1018886] [Reference Citation Analysis]
|
| 6 |
Garsetti DE, Sahay K, Wang Y, Rogers MB. Sex and the basal mRNA synthesis machinery. WIREs RNA 2022. [DOI: 10.1002/wrna.1765] [Reference Citation Analysis]
|
| 7 |
Tosi A, Parisatto B, Menegaldo A, Spinato G, Guido M, Del Mistro A, Bussani R, Zanconati F, Tofanelli M, Tirelli G, Boscolo-rizzo P, Rosato A. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors. J Exp Clin Cancer Res 2022;41:279. [DOI: 10.1186/s13046-022-02481-4] [Reference Citation Analysis]
|
| 8 |
Ghiani L, Chiocca S. High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies. Int J Mol Sci 2022;23:3483. [PMID: 35408843 DOI: 10.3390/ijms23073483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
